European Society of Toxicology In Vitro

Due to the COVID-19 pandemic and after thoughtful deliberation we have decided to postpone the congress to 2022 instead of the previously indicated dates in 2021. We kindly ask everyone to please save the new dates: 21-25 November 2022 . In the upcoming months, we will work on updating the website and determine a new list of important dates and deadlines for the congress. We look forward to gathering again in 2022 and in the meantime we wish everyone a healthy summer break!

The European Society of Toxicology In Vitro (ESTIV) will grant an early career award for the first time in 2020 and intends to do so every 2 years coinciding with its biennial conferences…

Human biology-based approaches for COVID 19 therapeutics – that is the theme of the July 8 webinars presented by Malcolm Wilkinson and Samuel Constant…

The European Commission’s Joint Research Centre (JRC) has instigated a project to assemble Adverse Outcome Pathways (AOP) describing the course of the Covid-19 disease from the molecular initiating event (e.g. ACE receptor binding) via a series of key events across different levels of biological organisation towards adverse clinical outcomes (e.g. respiratory failure, organ damage)…..